EPIRUS Biopharmaceuticals, Inc. Debt Conversion, Converted Instrument, Amount
EPIRUS Biopharmaceuticals, Inc. reported Debt Conversion, Converted Instrument, Amount of $13.18 million for the 12-month period ending 2014-12-31, per its 10-K filed 2016-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2016-03-29
- EPIRUS Biopharmaceuticals, Inc. debt conversion, converted instrument, amount for the quarter ending 2014-12-31 was $0.00.
- EPIRUS Biopharmaceuticals, Inc. debt conversion, converted instrument, amount for the quarter ending 2014-09-30 was $0.00.
- EPIRUS Biopharmaceuticals, Inc. debt conversion, converted instrument, amount for the quarter ending 2014-06-30 was $0.00.
- EPIRUS Biopharmaceuticals, Inc. debt conversion, converted instrument, amount for the quarter ending 2014-03-31 was $13.18M.
- EPIRUS Biopharmaceuticals, Inc. debt conversion, converted instrument, amount for fiscal 2014 was $13.18M.
- EPIRUS Biopharmaceuticals, Inc. debt conversion, converted instrument, amount for fiscal 2011 was $428.00K, a 470.67% increase from fiscal 2010.
- EPIRUS Biopharmaceuticals, Inc. debt conversion, converted instrument, amount for fiscal 2010 was $75.00K.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $0.00 derived: sum of 2 quarters · filed 2016-03-29 | $0.00 derived: sum of 3 quarters · filed 2016-03-29 | $13.18M 10-K · filed 2016-03-29 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $0.00 derived: sum of 2 quarters · filed 2015-11-16 | $13.18M 10-Q · filed 2015-11-16 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $13.18M 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | $13.18M 10-Q · filed 2015-05-13 | |||
| 2011-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $203.00K derived: sum of 2 quarters · filed 2014-03-14 | $428.00K 10-K · filed 2014-03-14 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $225.00K 10-Q · filed 2012-11-08 | ||
| 2011-06-30 | $225.00K 10-Q · filed 2012-08-07 | |||
| 2010-12-31 | $75.00K 10-K · filed 2013-03-07 |